Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
22.97
-0.12 (-0.52%)
At close: Sep 26, 2025, 4:00 PM EDT
23.10
+0.13 (0.57%)
After-hours: Sep 26, 2025, 7:54 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.26 billion as of September 26, 2025. Its market cap has increased by 18.38% in one year.
Market Cap
2.26B
Enterprise Value
1.26B
1-Year Change
18.38%
Ranking
Category
Stock Price
$22.97
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.26B, an increase of 588.29%. That is a compound annual growth rate of 40.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.26B | 14.36% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |